Taro Pharma: Letter from Grand Slam Asset

Grand Slam Asset Management has written a letter to Taro Pharma regarding the Sun Pharma offer price. We know that the offer of $24.50 is a discount to fair value of Taro. Similar to what happened to Caraco, I expect Sun Pharma to raise their offer once an independent committee does fair valuation for Taro.

Leave a Reply

%d bloggers like this: